Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 77.55 INR
Change Today 0.00 / 0.00%
Volume 0.0
WANB On Other Exchanges
Natl India
As of 7:06 AM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

wanbury ltd (WANB) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/9/15 - 79.55
52 Week Low
05/19/14 - 20.80
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for WANBURY LTD (WANB)

Related News

No related news articles were found.

wanbury ltd (WANB) Related Businessweek News

No Related Businessweek News Found

wanbury ltd (WANB) Details

Wanbury Limited manufactures and sells active pharmaceutical ingredients (API) in India and internationally. The company’s principal API product therapeutic areas include anti diabetic, anti analgesic, anti depressant, anti histaminic, anti inflammatory, anti arthritis, anti thrombotic, anti epileptic, and anti hypertensive. It also manufactures formulations for gynecology, orthopedics, heamatinics, neutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. Wanbury Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Founded in 1988

wanbury ltd (WANB) Top Compensated Officers

Vice Chairman, Compliance Officer, Chairman o...
Total Annual Compensation: 3.4M
Compensation as of Fiscal Year 2013.

wanbury ltd (WANB) Key Developments

Wanbury Ltd. Announces Unaudited Standalone Earnings Results for the Quarter Ended December 31, 2014

Wanbury Ltd. announced unaudited standalone earnings results for the quarter ended December 31, 2014. For the quarter, the company's net sales/income from operations was INR 1,252.0 million compared with INR 1,057.6 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 128.5 million compared with INR 48.8 million a year ago. Profit from ordinary activities before tax was INR 40.1 million compared with INR 13.5 million a year ago. Net profit was INR 34.2 million or INR 1.71 per basic and diluted share compared with INR 9.3 million or INR 0.66 per basic and diluted share a year ago.

Wanbury Ltd. to Report Q3, 2015 Results on Feb 11, 2015

Wanbury Ltd. announced that they will report Q3, 2015 results on Feb 11, 2015

Wanbury Ltd., Board Meeting, Feb 11, 2015

Wanbury Ltd., Board Meeting, Feb 11, 2015. Agenda: To consider and take on record the unaudited financial results of the company for the quarter ended December 31, 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WANB:IN 77.55 INR 0.00

WANB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for WANB.
View Industry Companies

Industry Analysis


Industry Average

Valuation WANB Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WANBURY LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at